Hip Replacement News and Research RSS Feed - Hip Replacement News and Research

Racial disparities exist for black and Hispanic patients undergoing major surgeries in U.S. hospitals

Racial disparities exist for black and Hispanic patients undergoing major surgeries in U.S. hospitals

Considerable racial disparities exist in surgical outcomes for black and Hispanic patients undergoing major cancer and non-cancer surgeries in U.S. hospitals, even among institutions that have already enrolled in a national surgical quality improvement initiative. [More]
XARELTO reduces rates of major bleeding, recurrent blood clots in people with deep vein thrombosis

XARELTO reduces rates of major bleeding, recurrent blood clots in people with deep vein thrombosis

Janssen Pharmaceuticals, Inc. and its development partner, Bayer HealthCare, today announced the results from their real-world study XALIA showing that, in people with deep vein thrombosis (DVT), the rates of major bleeding and recurrent blood clots for XARELTO (rivaroxaban) in routine clinical practice were generally consistent with those observed in Phase 3 research. [More]
New type of drug may help bones heal faster, better

New type of drug may help bones heal faster, better

Inspired by amphibians like salamanders, researchers from the University of Southampton are developing a new type of drug that may help bones heal faster and better. [More]
Research shows how scientists altered stem cells, triggered bone growth

Research shows how scientists altered stem cells, triggered bone growth

Imagine you have a bone fracture or a hip replacement, and you need bone to form, but you heal slowly - a common fact of life for older people. Instead of forming bone, you could form fat. Researchers at the University of North Carolina School of Medicine may have found a way to tip the scale in favor of bone formation. They used cytochalasin D, a naturally occurring substance found in mold, as a proxy to alter gene expression in the nuclei of mesenchymal stem cells to force them to become osteoblasts (bone cells). [More]
Excessive OR traffic during surgeries leads to postoperative infections

Excessive OR traffic during surgeries leads to postoperative infections

A “secret shopper” style study by researchers at Johns Hopkins analyzing foot traffic in and out of operating rooms suggests that for the sake of patient safety, OR teams may want to stay put more often. [More]
Miriam Hospital enrolling local participants for Parachute implant clinical trial to treat heart failure

Miriam Hospital enrolling local participants for Parachute implant clinical trial to treat heart failure

The Miriam Hospital is actively recruiting local participants for a U.S. clinical trial of the Parachute device for treating heart failure. The study is focused on determining if the new minimally invasive catheter-based device can slow the progression of heart failure, reduce repeat hospitalizations and death, and significantly improve quality of life for patients who experience enlargement of the left ventricle after a heart attack. [More]
PSH model of care saves cost, improves quality in second year

PSH model of care saves cost, improves quality in second year

Cost savings and quality improvement increased from the first year of implementation to the second in the Perioperative Surgical Home (PSH) model of care when used for knee or hip replacement patients at the University of California, Irvine School of Medicine, according to a study presented at the ANESTHESIOLOGY 2015 annual meeting. [More]
Hip fracture patients have worse outcomes compared to hip replacement patients

Hip fracture patients have worse outcomes compared to hip replacement patients

Many surgeons and physicians have assumed that patients undergoing surgery for a hip fracture have a higher risk of death and major complications compared to patients undergoing an elective total hip replacement because patients having surgery for a hip fracture are older and have more chronic diseases than patients having an elective hip surgery. [More]
Janssen, Bayer HealthCare announce results from landmark studies evaluating safety profile of XARELTO in NVAF patients

Janssen, Bayer HealthCare announce results from landmark studies evaluating safety profile of XARELTO in NVAF patients

Janssen Pharmaceuticals, Inc., and its development partner, Bayer HealthCare, today announced results from PMSS (Post-Marketing Safety Surveillance) and XANTUS (XARELTO for Prevention of Stroke in Patients with Atrial Fibrillation), their landmark real-world studies evaluating the safety of XARELTO in people with non-valvular atrial fibrillation (NVAF). [More]
Study: Knee or hip replacement surgery may increase heart attack risk

Study: Knee or hip replacement surgery may increase heart attack risk

Contrary to recent reports, Boston-based researchers found that osteoarthritis patients who had total knee or hip joint replacement surgery, known as arthroplasty, were at increased risk of heart attack (myocardial infarction) in the early post-operative period. [More]
Scientists publish new important clues about marrow fat

Scientists publish new important clues about marrow fat

While most of us worry about the fat cells building up on the fleshy parts of our bodies, scientists have started to pay serious attention to another kind of fat cell deep inside our bones, in what's called the marrow. [More]
Mercy Medical Center named third best hospital in Maryland

Mercy Medical Center named third best hospital in Maryland

U.S. News & World Report has released its annual "Best Hospital" rankings. This 26th annual edition includes information on nearly 5,000 hospitals nationwide. U.S. News & World Report named Mercy Medical Center in Baltimore as the third best hospital in Maryland, behind only the academic medical centers at Johns Hopkins and the University of Maryland. Mercy also retained its status from last year as the state's top-ranked community hospital. [More]
Consumers get access to nationwide ratings of individual surgeons based on patient outcomes

Consumers get access to nationwide ratings of individual surgeons based on patient outcomes

Preventable medical errors of various kinds kill at least 200,000 Americans each year, making this the third leading cause of death in the United States, six times as many deaths as from auto accidents. One way to reduce such errors is for consumers to choose the best surgeons. For the first time ever, consumers across the U.S. today have access to ratings of individual surgeons based on outcomes—how often their patients die in hospital or within 90 days of hospital discharge, have serious complications in hospital, or need to be readmitted to a hospital within 90 days of discharge. [More]
Connexient, RWJUH announce public launch of MediNav Navigator Edition 2.0

Connexient, RWJUH announce public launch of MediNav Navigator Edition 2.0

Connexient and Robert Wood Johnson University Hospital announced this week the public launch of MediNav Navigator Edition 2.0. This makes RWJUH the first hospital in North America to deliver for its patients, visitors and staff the world's first true turn-by-turn indoor navigation smartphone application, with reliable indoor positioning accuracy of one to two meters. [More]
Janssen, Bayer HealthCare initiate CALLISTO program to study rivaroxaban in patients with active cancer

Janssen, Bayer HealthCare initiate CALLISTO program to study rivaroxaban in patients with active cancer

Janssen Pharmaceuticals, Inc. and its development partner, Bayer HealthCare, today announced the initiation of CALLISTO, a new comprehensive clinical research program for their novel oral anticoagulant, rivaroxaban, in patients with active cancer. The studies are evaluating the medicine for the prevention and treatment of life-threatening blood clots in patients with a wide range of cancer types. [More]
Researchers design new model to identify promising candidates for total hip replacement surgery

Researchers design new model to identify promising candidates for total hip replacement surgery

Researchers at Sahlgrenska Academy have designed a new model to help doctors and patients decide whether or not to proceed with total hip replacement surgery. The researchers have also surveyed patient wellbeing after surgery: patients with high education achieve greater outcome scores, while those with antidepressant prescriptions do not. [More]
Mayo Clinic hospitals earn top-tier High Performing distinction in U.S. News & World Report ratings

Mayo Clinic hospitals earn top-tier High Performing distinction in U.S. News & World Report ratings

Mayo Clinic Hospitals in Rochester, Minn, and Phoenix earned the top-tier High Performing distinction in all five common care categories in the latest ratings by U.S. News & World Report. [More]

Kaiser Permanente, Intermountain Healthcare to participate in U.S. News Hospital Outcome Data Disclosure Program

U.S. News & World Report, publisher of Best Hospitals and Best Children's Hospitals, today announced that Kaiser Permanente and Intermountain Healthcare will participate in the U.S. News Hospital Outcome Data Disclosure Program, a new data-collection initiative designed to evaluate hospitals more completely and give patients better information about the hospitals in their communities. [More]
Boehringer Ingelheim seeks FDA approval for Pradaxa to treat DVT and PE

Boehringer Ingelheim seeks FDA approval for Pradaxa to treat DVT and PE

Legal-Bay LLC, The Lawsuit Settlement Funding Company, announced today that Pradaxa's maker, Boehringer Ingelheim Pharmaceuticals, is seeking FDA approval for its blood thinner to treat DVT and PE. [More]
Radlink, DePuy Synthes sign exclusive worldwide sales agency agreement

Radlink, DePuy Synthes sign exclusive worldwide sales agency agreement

Radlink, Inc., an emerging global leader in advanced medical imaging technology, announced today that it has signed an exclusive worldwide sales agency agreement with Johnson & Johnson subsidiary DePuy Synthes Companies. The contractual partnership provides for the exclusive worldwide distribution of Radlink's advanced imaging products, including the revolutionary Galileo Positioning System (GPS) featuring Surgeon's Checklist software, through DePuy Synthes Companies' sales representatives worldwide. [More]
Advertisement
Advertisement